Adam Yaari net worth
Quick answer
Adam Yaari's estimated net worth is $12.0M (range $8.4M – $18.0M) as of 2026. Adam Yaari is CEO at Serinus Biosciences. Serinus Biosciences valuation.
Adam Yaari is CEO at Serinus Biosciences (YC S22). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Background: Israeli
- Education: PhD and MS in computer science from MIT; MSc in computer science and mathematics from the Weizmann Institute of Science; dual major BSc in computer science and neuroscience from Bar-Ilan University
- Region: United States of America
- Industries: Healthcare, Therapeutics
- Team size: 6
- Website: http://www.serinus.bio
Who is Adam Yaari?
Adam Yaari is the founder of Serinus Biosciences, leveraging over a decade of entrepreneurship experience and advanced AI models for biological research. He holds multiple degrees in computer science and neuroscience, including a PhD from MIT.
Highlights:
- Microsoft R&D Fellowship
- Flagship Pioneering Ideation Fellowship
- PhD and MS in computer science from MIT
Background
He completed his undergraduate and master's degrees in Israel. Heritage/background labels may be inferred and are not verified identity documents.
About Serinus Biosciences
Serinus Biosciences is tackling one of the toughest problems in cancer treatment: creating combination therapies to override treatment resistance. We leverage cutting edge technology to design a fully explainable AI platform primed with decades of system biology knowledge. Uniquely powered for biological inference, our AI engine uncovers how cancer cells evolve treatment resistance and identifies molecules to...
FAQ: Adam Yaari net worth and Serinus Biosciences valuation
What is Adam Yaari's net worth?
Adam Yaari's estimated net worth is $12.0M (range $8.4M – $18.0M) as of 2026. Adam Yaari is CEO at Serinus Biosciences. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Serinus Biosciences valuation?
Serinus Biosciences's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Adam Yaari's role?
Adam Yaari is CEO at Serinus Biosciences, a Y Combinator-backed startup (batch S22).